Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 4 minute read Pharma Industry News PepGen brings in gene therapy veteran to accelerate breakthrough neuromuscular treatments PepGen names gene therapy veteran Kasra Kasraian as CTO to scale up oligonucleotide therapies for neuromuscular diseases. Find out what this means for investors. byPallavi MadhirajuMay 20, 2025